“AiVF’s solution could dramatically improve the chances of successful IVF treatments and lower their cost in the EU, thus reducing the suffering of those going through the IVF process and enabling millions of others to fulfill their dream of having a baby,” she said.Accompanying the CE approval, AViF also appointed an expert in the field of behavioral economics, Prof. Dan Ariely, as its new chief behavioral officer.AViF's was established in order to create the most advanced technologies to revolutionize the field of IVF, by helping to close the gaps between the demands for these types of treatments and the clinics that can meet those demands.IVF treatments in the US traditionally cost around $20,000, with around five rounds of treatment. The AViF platform raises the chances of success for that investment substantially, with the chances of pregnancy much higher, and fewer rounds of treatment in the process.“Traditional embryo evaluation technique is performed manually and is not AI-data driven," said co-founder and Chief Medical Officer at AiVF Prof. Daniel Seidman. "AiVF’s studies show remarkable accuracy, proving that a digital system can outperform an embryologist in making IVF decisions. With AiVF technology now commercially available in Europe and soon in the US, we can offer the first-in-class product to improve the chances of pregnancy and of delivering a healthy baby to the world.”
Israeli IVF treatment developer earns CE approval for AI-based solution
The platform, EMA TM, has garnered approval from the CE certifying body to market its innovative product for use in IVF fertility clinics across Europe.
